Iron deficiency anemia in pregnancy: Subgroup analysis from Riyadh mother and baby multicenter cohort study (RAHMA)

Q4 Medicine
H. Wahabi, S. Esmaeil, Hala Elmorshedy, H. Bakhsh, Aalaa Abdelrahman, A. Fayed
{"title":"Iron deficiency anemia in pregnancy: Subgroup analysis from Riyadh mother and baby multicenter cohort study (RAHMA)","authors":"H. Wahabi, S. Esmaeil, Hala Elmorshedy, H. Bakhsh, Aalaa Abdelrahman, A. Fayed","doi":"10.4103/joah.joah_133_21","DOIUrl":null,"url":null,"abstract":"OBJECTIVES: The objective of the study was to estimate the prevalence and risk factors of anemia among pregnant women in Riyadh and to examine its association with adverse pregnancy outcomes. METHODS: This study is a subgroup analysis from Riyadh mother and baby multicenter cohort study. Participants were grouped into four groups according to hemoglobin level: nonanemic (≥11.0 g/100 ml), mild (10–10.9 g/100 ml), moderate (7.0–9.9 g/100 ml), and severe anemia (<7.0 g/100 ml). Regression analyses were conducted to extrapolate the predicted probability (PP) for pregnancy outcomes. RESULTS: Out of 10,600 participants, 3261 (30.76%) were anemic; 1729 (16.3%), 1520 (14.3%), and 12 (0.1%) had mild, moderate, and severe anemia, respectively. The odds of anemia was higher in younger mothers (odds ratio [OR] = 0.94, confidence interval [CI]: 0.91–0.94) and in primiparous (OR = 1.01, CI: 0.90–1.14), while attendants of antenatal care and those who received iron supplements were less likely to be anemic (OR = 0.93, CI: 0.82–1.06) and (OR = 0.92, CI: 0.77–1.09), respectively. There was a significant increase in the odds of lower APGAR with the decreased hemoglobin; an increment of maternal hemoglobin by 1 g/100 ml decreased the likelihood of APGAR scores <7 by 9% (OR = 0.91, CI: 0.83–0.99). The PP showed a decrease in preterm birth (PTB) rate from 8% (CI: 6%–9%) to 6.5% (CI: 5%–8%), low birth weight (LBW) rate from 12% (CI 10%–13%) to 11% (CI: 9%–12%), stillbirth rate from 1.3% (CI: 0.7%–2.1%) to 1.1% (CI: 0.7%–1.6%), and maternal admission to intensive care unit (ICU) from 0.8% (CI: 0.2%–1.5%) to 0.2% (CI: 0.06%–0.4%), with increase of maternal hemoglobin from 7 g/100 ml to 15 g/100 ml. CONCLUSION: More than a third of the pregnant women in Riyadh had mild-to-moderate anemia. The odds of anemia increased in primipara, younger mothers, and those without antenatal care or iron supplementation. PP showed that anemia is associated with low APGAR scores, LBW, PTB stillbirth, and maternal admission to ICU.","PeriodicalId":36501,"journal":{"name":"Journal of Applied Hematology","volume":"13 1","pages":"47 - 53"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Applied Hematology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/joah.joah_133_21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

OBJECTIVES: The objective of the study was to estimate the prevalence and risk factors of anemia among pregnant women in Riyadh and to examine its association with adverse pregnancy outcomes. METHODS: This study is a subgroup analysis from Riyadh mother and baby multicenter cohort study. Participants were grouped into four groups according to hemoglobin level: nonanemic (≥11.0 g/100 ml), mild (10–10.9 g/100 ml), moderate (7.0–9.9 g/100 ml), and severe anemia (<7.0 g/100 ml). Regression analyses were conducted to extrapolate the predicted probability (PP) for pregnancy outcomes. RESULTS: Out of 10,600 participants, 3261 (30.76%) were anemic; 1729 (16.3%), 1520 (14.3%), and 12 (0.1%) had mild, moderate, and severe anemia, respectively. The odds of anemia was higher in younger mothers (odds ratio [OR] = 0.94, confidence interval [CI]: 0.91–0.94) and in primiparous (OR = 1.01, CI: 0.90–1.14), while attendants of antenatal care and those who received iron supplements were less likely to be anemic (OR = 0.93, CI: 0.82–1.06) and (OR = 0.92, CI: 0.77–1.09), respectively. There was a significant increase in the odds of lower APGAR with the decreased hemoglobin; an increment of maternal hemoglobin by 1 g/100 ml decreased the likelihood of APGAR scores <7 by 9% (OR = 0.91, CI: 0.83–0.99). The PP showed a decrease in preterm birth (PTB) rate from 8% (CI: 6%–9%) to 6.5% (CI: 5%–8%), low birth weight (LBW) rate from 12% (CI 10%–13%) to 11% (CI: 9%–12%), stillbirth rate from 1.3% (CI: 0.7%–2.1%) to 1.1% (CI: 0.7%–1.6%), and maternal admission to intensive care unit (ICU) from 0.8% (CI: 0.2%–1.5%) to 0.2% (CI: 0.06%–0.4%), with increase of maternal hemoglobin from 7 g/100 ml to 15 g/100 ml. CONCLUSION: More than a third of the pregnant women in Riyadh had mild-to-moderate anemia. The odds of anemia increased in primipara, younger mothers, and those without antenatal care or iron supplementation. PP showed that anemia is associated with low APGAR scores, LBW, PTB stillbirth, and maternal admission to ICU.
孕期缺铁性贫血:来自利雅得母婴多中心队列研究(RAHMA)的亚组分析
目的:本研究的目的是估计利雅得孕妇贫血的患病率和危险因素,并研究其与不良妊娠结局的关系。方法:本研究是来自利雅得母婴多中心队列研究的亚组分析。根据血红蛋白水平将参与者分为四组:非贫血(≥11.0 g/100 ml)、轻度(10-10.9 g/100 ml)、中度(7.0 - 9.9 g/100 ml)和重度贫血(<7.0 g/100 ml)。采用回归分析推断妊娠结局的预测概率(PP)。结果:在10,600名参与者中,3261名(30.76%)贫血;1729例(16.3%)、1520例(14.3%)和12例(0.1%)分别患有轻度、中度和重度贫血。年轻母亲患贫血的几率较高(比值比[OR] = 0.94,可信区间[CI]: 0.91-0.94),初产妇患贫血的几率较高(OR = 1.01,可信区间[CI]: 0.90-1.14),而产前护理人员和接受铁补充剂的孕妇患贫血的几率较低(OR = 0.93,可信区间[CI]: 0.82-1.06)和(OR = 0.92,可信区间[CI]: 0.77-1.09)。随着血红蛋白的降低,APGAR降低的几率显著增加;母体血红蛋白每增加1 g/100 ml, APGAR评分<7的可能性降低9% (OR = 0.91, CI: 0.83-0.99)。页显示减少早产(PTB)利率从8% (-9% CI: 6%) 6.5% (-8% CI: 5%),低出生体重(激光焊)利率从12% (-13% CI 10%)至11% (9% CI: -12%),死产率从1.3% (-2.1% CI: 0.7%) 1.1% (-1.6% CI: 0.7%),和产妇进入重症监护室(ICU)从0.8% (-1.5% CI: 0.2%) 0.2% (-0.4% CI: 0.06%),增加的母体血红蛋白从7 g / 100毫升15 g / 100毫升。结论:三分之一以上的孕妇在利雅得轻度到中度贫血。初产妇、年轻母亲和没有产前保健或铁补充剂的母亲患贫血的几率增加。PP显示贫血与低APGAR评分、低体重、PTB死产和产妇入住ICU有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Applied Hematology
Journal of Applied Hematology Medicine-Hematology
CiteScore
0.40
自引率
0.00%
发文量
34
审稿时长
24 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信